ArticleFrontiers in oncology2023

Effectiveness of chemotherapy using bortezomib combined with homoharringtonine and cytarabine in refractory or relapsed acute myeloid leukemia: a phase II, multicenter, prospective clinical trial.

Chengtao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.